Comparative study of the metabolism of drug substrates by human cytochrome P450 3A4 expressed in bacterial, yeast and human lymphoblastoid cells
暂无分享,去创建一个
J B Houston | J. Houston | N. Randolph | T. Friedberg | D. Carlile | D J Carlile | M. Abd-Ellah | T Friedberg | K E Kenworthy | J Andrews | M F Abd-Ellah | N L Randolph | K. Kenworthy | J. Andrews
[1] J. Houston,et al. Diazepam-omeprazole inhibition interaction: an in vitro investigation using human liver microsomes. , 1996, British journal of clinical pharmacology.
[2] A. Somogyi,et al. The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes. , 1994, British journal of clinical pharmacology.
[3] P. Thomas,et al. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450. , 1996, Drug metabolism and disposition: the biological fate of chemicals.
[4] B. Ring,et al. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone. , 1998, Pharmacogenetics.
[5] H. Yamazaki,et al. Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b(5) in bacterial membranes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[6] A. Somogyi,et al. Simultaneous Determination of Dextromethorphan and Three Metabolites in Plasma and Urine Using High‐Performance Liquid Chromatography with Application to Their Disposition in Man , 1990, Therapeutic drug monitoring.
[7] K. Korzekwa,et al. Role of cDNA-expressed human cytochromes P450 in the metabolism of diazepam. , 1998, Biochemical pharmacology.
[8] T. Baillie,et al. Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives. , 1999, The Biochemical journal.
[9] C. Wolf,et al. Effects of human cytochrome b5 on CYP3A4 activity and stability in vivo. , 1999, Archives of biochemistry and biophysics.
[10] Aiming Yu,et al. Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities? , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[11] J. Miners,et al. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. , 1994, British journal of clinical pharmacology.
[12] D. Mansuy,et al. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5. , 1992, European journal of biochemistry.
[13] K. Korzekwa,et al. Cytochromes P450 Expression Systems , 1995 .
[14] J. Houston,et al. Sigmoidal kinetics of CYP3A substrates: an approach for scaling dextromethorphan metabolism in hepatic microsomes and isolated hepatocytes to predict in vivo clearance in rat. , 1999, The Journal of pharmacology and experimental therapeutics.
[15] C. Wolf,et al. Recombinant DNA technology as an investigative tool in drug metabolism research , 1996 .
[16] T. Omura,et al. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.
[17] C. Funck-Brentano,et al. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans. , 1993, Pharmacogenetics.
[18] T. Kost,et al. CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. , 1995, Archives of biochemistry and biophysics.
[19] R. Amrein,et al. Pharmacology of Dormicum (midazolam) and Anexate (flumazenil) , 1990, Acta anaesthesiologica Scandinavica. Supplementum.
[20] S D Hall,et al. Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily. , 1994, Biochemical pharmacology.
[21] H. Iwata,et al. High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. , 1998, Biochemical pharmacology.
[22] F. Guengerich,et al. Expression of mammalian cytochrome P450 enzymes using yeast-based vectors. , 1991, Methods in enzymology.
[23] M. J. Coon,et al. Purified liver microsomal NADPH-cytochrome P-450 reductase. Spectral characterization of oxidation-reduction states. , 1978, The Journal of biological chemistry.
[24] C. Wolf,et al. Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli , 1996, FEBS letters.
[25] D. Thompson,et al. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-dealkylation of diazepam and temazepam. , 1990, Molecular pharmacology.
[26] J. Houston,et al. Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data. , 1995, The Journal of pharmacology and experimental therapeutics.
[27] R J Riley,et al. Rapid characterization of the major drug-metabolizing human hepatic cytochrome P-450 enzymes expressed in Escherichia coli. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[28] H. Yamazaki,et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.
[29] T. Kronbach,et al. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. , 1989, Molecular pharmacology.
[30] S. Wrighton,et al. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily. , 1994, Biochemical pharmacology.
[31] C. Crespi. Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research , 1995 .
[32] T. Richardson,et al. Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam N-demethylases. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[33] Y Wang,et al. Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[34] F. Guengerich,et al. Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. , 1993, Archives of biochemistry and biophysics.
[35] I. Wainer,et al. Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity. , 1996, Journal of chromatography. B, Biomedical applications.
[36] J B Houston,et al. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[37] B. W. Penman,et al. Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions. , 1997, Advances in pharmacology.
[38] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[39] K. Korzekwa,et al. Cytochromes P450 expression systems. , 1995, Annual review of pharmacology and toxicology.